1. Market Overview of Immune Globulins
1.1 Immune Globulins Market Overview
1.1.1 Immune Globulins Product Scope
1.1.2 Market Status and Outlook
1.2 Immune Globulins Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Immune Globulins Historic Market Size by Regions (2015-2020)
1.4 Immune Globulins Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Immune Globulins Sales Market by Type (2015-2026)
2.1 Global Immune Globulins Historic Market Size by Type (2015-2020)
2.2 Global Immune Globulins Forecasted Market Size by Type (2021-2026)
2.3 IVIg Liquid
2.4 IVIg Powder
3. Covid-19 Impact Immune Globulins Sales Market by Application (2015-2026)
3.1 Global Immune Globulins Historic Market Size by Application (2015-2020)
3.2 Global Immune Globulins Forecasted Market Size by Application (2021-2026)
3.3 Immunodeficiency
3.4 Autoimmune Disease
3.5 Acute Infection
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Immune Globulins Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Immune Globulins Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Immune Globulins Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Immune Globulins Business
5.1 Baxter
5.1.1 Baxter Company Profile
5.1.2 Baxter Immune Globulins Product Specification
5.1.3 Baxter Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Grifols
5.2.1 Grifols Company Profile
5.2.2 Grifols Immune Globulins Product Specification
5.2.3 Grifols Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 CSL
5.3.1 CSL Company Profile
5.3.2 CSL Immune Globulins Product Specification
5.3.3 CSL Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Octapharma
5.4.1 Octapharma Company Profile
5.4.2 Octapharma Immune Globulins Product Specification
5.4.3 Octapharma Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Biotest
5.5.1 Biotest Company Profile
5.5.2 Biotest Immune Globulins Product Specification
5.5.3 Biotest Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Kedrion
5.6.1 Kedrion Company Profile
5.6.2 Kedrion Immune Globulins Product Specification
5.6.3 Kedrion Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Hualan Bio
5.7.1 Hualan Bio Company Profile
5.7.2 Hualan Bio Immune Globulins Product Specification
5.7.3 Hualan Bio Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 CNBG
5.8.1 CNBG Company Profile
5.8.2 CNBG Immune Globulins Product Specification
5.8.3 CNBG Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Shanghai RAAS
5.9.1 Shanghai RAAS Company Profile
5.9.2 Shanghai RAAS Immune Globulins Product Specification
5.9.3 Shanghai RAAS Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 CBPO
5.10.1 CBPO Company Profile
5.10.2 CBPO Immune Globulins Product Specification
5.10.3 CBPO Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 LFB Group
5.11.1 LFB Group Company Profile
5.11.2 LFB Group Immune Globulins Product Specification
5.11.3 LFB Group Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 BPL
5.12.1 BPL Company Profile
5.12.2 BPL Immune Globulins Product Specification
5.12.3 BPL Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Sichuan Yuanda Shuyang
5.13.1 Sichuan Yuanda Shuyang Company Profile
5.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Specification
5.13.3 Sichuan Yuanda Shuyang Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Immune Globulins Market Size (2015-2026)
6.2 North America Immune Globulins Key Players in North America (2015-2020)
6.3 North America Immune Globulins Market Size by Type (2015-2020)
6.4 North America Immune Globulins Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Immune Globulins Market Size (2015-2026)
7.2 East Asia Immune Globulins Key Players in North America (2015-2020)
7.3 East Asia Immune Globulins Market Size by Type (2015-2020)
7.4 East Asia Immune Globulins Market Size by Application (2015-2020)
8. Europe
8.1 Europe Immune Globulins Market Size (2015-2026)
8.2 Europe Immune Globulins Key Players in North America (2015-2020)
8.3 Europe Immune Globulins Market Size by Type (2015-2020)
8.4 Europe Immune Globulins Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Immune Globulins Market Size (2015-2026)
9.2 South Asia Immune Globulins Key Players in North America (2015-2020)
9.3 South Asia Immune Globulins Market Size by Type (2015-2020)
9.4 South Asia Immune Globulins Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Immune Globulins Market Size (2015-2026)
10.2 Southeast Asia Immune Globulins Key Players in North America (2015-2020)
10.3 Southeast Asia Immune Globulins Market Size by Type (2015-2020)
10.4 Southeast Asia Immune Globulins Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Immune Globulins Market Size (2015-2026)
11.2 Middle East Immune Globulins Key Players in North America (2015-2020)
11.3 Middle East Immune Globulins Market Size by Type (2015-2020)
11.4 Middle East Immune Globulins Market Size by Application (2015-2020)
12. Africa
12.1 Africa Immune Globulins Market Size (2015-2026)
12.2 Africa Immune Globulins Key Players in North America (2015-2020)
12.3 Africa Immune Globulins Market Size by Type (2015-2020)
12.4 Africa Immune Globulins Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Immune Globulins Market Size (2015-2026)
13.2 Oceania Immune Globulins Key Players in North America (2015-2020)
13.3 Oceania Immune Globulins Market Size by Type (2015-2020)
13.4 Oceania Immune Globulins Market Size by Application (2015-2020)
14. South America
14.1 South America Immune Globulins Market Size (2015-2026)
14.2 South America Immune Globulins Key Players in North America (2015-2020)
14.3 South America Immune Globulins Market Size by Type (2015-2020)
14.4 South America Immune Globulins Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Immune Globulins Market Size (2015-2026)
15.2 Rest of the World Immune Globulins Key Players in North America (2015-2020)
15.3 Rest of the World Immune Globulins Market Size by Type (2015-2020)
15.4 Rest of the World Immune Globulins Market Size by Application (2015-2020)
16 Immune Globulins Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.